RU2004125580A - Способ получения 7альфа-метилстероидов - Google Patents

Способ получения 7альфа-метилстероидов Download PDF

Info

Publication number
RU2004125580A
RU2004125580A RU2004125580/04A RU2004125580A RU2004125580A RU 2004125580 A RU2004125580 A RU 2004125580A RU 2004125580/04 A RU2004125580/04 A RU 2004125580/04A RU 2004125580 A RU2004125580 A RU 2004125580A RU 2004125580 A RU2004125580 A RU 2004125580A
Authority
RU
Russia
Prior art keywords
steroid
copper
grignard reagent
formula
hydroxy
Prior art date
Application number
RU2004125580/04A
Other languages
English (en)
Other versions
RU2305105C2 (ru
Inventor
Й. Стулвиндер (Nl)
Й. Стулвиндер
М. Остендорф (Nl)
М. Остендорф
Ван П.А.М. БЮГЕНЮМ (NL)
Ван П.А.М. БЮГЕНЮМ
Original Assignee
Акцо Нобель Н.В. (NL)
Акцо Нобель Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акцо Нобель Н.В. (NL), Акцо Нобель Н.В. filed Critical Акцо Нобель Н.В. (NL)
Publication of RU2004125580A publication Critical patent/RU2004125580A/ru
Application granted granted Critical
Publication of RU2305105C2 publication Critical patent/RU2305105C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0085Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Claims (10)

1. Способ получения 7α-метилстероидов формулы I
Figure 00000001
где R1 представляет собой водород, метил или С≡СН;
R2 представляет собой (СН2)nOH, где n равно 0, 1 или 2,
опосредованным медью 1,6-сопряженным присоединением реактива Гриньяра СН3MgX, причем Х является галогеном, к 4,6-ненасыщенному 3-кетостероиду формулы II
Figure 00000002
где R1 и R2 имеют значения, указанные ранее,
включающий защиту гидроксигруппы стероида формулы II триалкилсилильной группой с последующей обработкой гидроксизащищенного стероида реактивом Гриньяра.
2. Способ по п. 1, где R1 представляет собой водород, метил или С≡СН и R2 представляет собой ОН или R1 представляет собой водород и R2 представляет собой (СН2)2ОН.
3. Способ по п. 1 или 2, где реактив Гриньяра представляет собой СН3MgCl.
4. Способ по п. 1 или 2, где триалкилсилильной группой является триметилсилильная группа.
5. Способ по п. 1 или 2, где растворителем реакции Гриньяра является тетрагидрофуран, диэтиловый эфир или их смесь.
6. Способ по п. 1 или 2, где концентрация стероида является 0,1-0,3 молярной.
7. Способ по п. 1 или 2, где молярное отношение стероида к реактиву Гриньяра составляет 1:1 - 1:7.
8. Способ по п. 1 или 2, где в качестве медного катализатора используют ацетат меди(II) или хлорид меди(II).
9. Способ по п. 1 или 2, где температура реакции Гриньяра составляет от -78 до 0°С.
10. Соединение 21-гидрокси-19-норпрегн-4,6-диен-3-он.
RU2004125580/04A 2002-01-21 2003-01-14 СПОСОБ ПОЛУЧЕНИЯ 7α-МЕТИЛСТЕРОИДОВ, СОЕДИНЕНИЕ RU2305105C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075230 2002-01-21
EP02075230.9 2002-01-21

Publications (2)

Publication Number Publication Date
RU2004125580A true RU2004125580A (ru) 2006-01-27
RU2305105C2 RU2305105C2 (ru) 2007-08-27

Family

ID=8185555

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004125580/04A RU2305105C2 (ru) 2002-01-21 2003-01-14 СПОСОБ ПОЛУЧЕНИЯ 7α-МЕТИЛСТЕРОИДОВ, СОЕДИНЕНИЕ

Country Status (28)

Country Link
US (2) US20050090476A1 (ru)
EP (1) EP1470151B1 (ru)
JP (1) JP5250174B2 (ru)
KR (1) KR100937179B1 (ru)
CN (1) CN100372864C (ru)
AR (1) AR038165A1 (ru)
AT (1) ATE453659T1 (ru)
AU (1) AU2003205604B8 (ru)
BR (1) BRPI0306736B8 (ru)
CA (1) CA2472379C (ru)
DE (1) DE60330749D1 (ru)
EC (1) ECSP045180A (ru)
EG (1) EG23417A (ru)
ES (1) ES2336439T3 (ru)
HR (1) HRP20040634B1 (ru)
IL (2) IL162770A0 (ru)
IS (1) IS2740B (ru)
MX (1) MXPA04007049A (ru)
NO (1) NO327095B1 (ru)
NZ (1) NZ533970A (ru)
PE (1) PE20030926A1 (ru)
PL (1) PL208163B1 (ru)
RO (1) RO122913B1 (ru)
RS (1) RS51490B (ru)
RU (1) RU2305105C2 (ru)
TW (1) TWI322813B (ru)
WO (1) WO2003059931A1 (ru)
ZA (1) ZA200405257B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR100716981B1 (ko) * 2004-09-30 2007-05-10 삼성전자주식회사 대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기
JP5749261B2 (ja) * 2009-06-29 2015-07-15 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー 3,3,5,5−テトラメチルシクロヘキサノンを調製する方法
CN111944001A (zh) * 2020-07-09 2020-11-17 浙江神洲药业有限公司 一种替勃龙的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3470216A (en) * 1966-11-29 1969-09-30 Du Pont Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (ru) * 1969-07-28 1973-06-08 Roussel Uclaf
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
JPS56145239A (en) * 1980-04-11 1981-11-11 Sumitomo Chem Co Ltd Novel bicyclooctane derivative and its preparation
US4298559A (en) * 1980-07-23 1981-11-03 Dow Corning Corporation High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
IL149424A (en) * 1999-12-02 2007-05-15 Organon Nv Androgens are converted to methylene at positions 15,14
WO2001058919A2 (en) * 2000-02-11 2001-08-16 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
NZ533970A (en) 2005-10-28
US20050090476A1 (en) 2005-04-28
IL162770A (en) 2011-06-30
CA2472379C (en) 2010-05-25
RO122913B1 (ro) 2010-04-30
EG23417A (en) 2005-06-28
US20100204497A1 (en) 2010-08-12
CA2472379A1 (en) 2003-07-24
IL162770A0 (en) 2005-11-20
ZA200405257B (en) 2005-08-31
ECSP045180A (es) 2004-08-27
NO327095B1 (no) 2009-04-20
TWI322813B (en) 2010-04-01
JP2005519899A (ja) 2005-07-07
AU2003205604B2 (en) 2009-11-26
WO2003059931A1 (en) 2003-07-24
AU2003205604B8 (en) 2009-12-24
JP5250174B2 (ja) 2013-07-31
BR0306736A (pt) 2004-12-28
AU2003205604A1 (en) 2003-07-30
BRPI0306736B1 (pt) 2017-11-07
RS51490B (sr) 2011-04-30
RU2305105C2 (ru) 2007-08-27
DE60330749D1 (de) 2010-02-11
HRP20040634B1 (hr) 2013-07-31
EP1470151B1 (en) 2009-12-30
NO20043455L (no) 2004-08-19
KR100937179B1 (ko) 2010-01-19
ATE453659T1 (de) 2010-01-15
MXPA04007049A (es) 2004-10-14
ES2336439T3 (es) 2010-04-13
PL371583A1 (en) 2005-06-27
TW200302731A (en) 2003-08-16
EP1470151A1 (en) 2004-10-27
PL208163B1 (pl) 2011-03-31
KR20040077727A (ko) 2004-09-06
CN100372864C (zh) 2008-03-05
CN1863814A (zh) 2006-11-15
IS2740B (is) 2011-06-15
PE20030926A1 (es) 2003-10-29
HRP20040634A2 (en) 2004-10-31
IS7339A (is) 2004-06-28
AR038165A1 (es) 2004-12-29
YU63004A (sh) 2006-08-17
BRPI0306736B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
Kawachi et al. Preparations and Reactions of Functionalized Silyllithiums.
RU2007116248A (ru) Способ получения производных 3-аминопиперидина
CA2516319A1 (en) Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
ATE37807T1 (de) Platin-alkenylzyklohexenkomplex als katalysator fuer die hydrosilylationsreaktion und verfahren zu seiner herstellung.
Tamao et al. Silafunctional compounds in organic synthesis: XVIII. Oxidative cleavage of the silicon-carbon bond in alkenylfluorosilanes to carbonyl compounds: Synthetic and mechanistic aspects
Damrauer et al. Gas-phase acidities of methylsilanes: carbon-hydrogen versus silicon-hydrogen
Schmid et al. Propargylsilane function as a terminator of biomimetic polyene cyclizations leading to steroids
CN105254697A (zh) △16甾体类化合物的制备方法
RU2004125580A (ru) Способ получения 7альфа-метилстероидов
CN110669066A (zh) 一种二硅烷及其制备方法
CA2019691C (en) Preparation of tertiary-hydrocarbylsilyl compounds
Yamazaki et al. 1, 1, 2, 2-Tetraphenyldisilane as a diversified radical reagent
ATE334938T1 (de) Verfahren zur herstellung von organohalogensilanen aus amorphem silizium
JPS61263986A (ja) 有機けい素化合物
KR950032234A (ko) 실라시클로헥산 카르보알데히드 화합물 및 카르보알데히드 화합물을 사용하는 실라시클로헥산계 액정의 제조방법
Westermark et al. Preparation of some organic silicon hydrides
JP2009269820A (ja) かご型シロキサン化合物の製造方法
JPH05202073A (ja) 第3級炭化水素シリル化合物の製造方法
CN114634524A (zh) 一种二甲基乙烯基氯硅烷的制备方法及其应用
JP2938726B2 (ja) 第3級ブチルシクロアルキルジアルコキシシラン化合物の製造方法
Miller et al. Grignard Addition to Alkynols
JP3816278B2 (ja) 1,2−ジカルボニル化合物の製造法
JP3419207B2 (ja) 3−アミノプロピルアルコキシシラン化合物の製造方法
JP2000086675A (ja) シランの製造法
Schlegel et al. Theoretical study of reaction pathways for F-+ H3SiCHO

Legal Events

Date Code Title Description
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20120326

PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20130917

PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20140402